Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

Breast Cancer

While the precise mechanism is unclear, clinicians’ expression of empathy vastly improves patient retention of information.
Diet and exercise should be consistently addressed as part of oncology visits for improved patient outcomes.
Treatment with CDK4/6 inhibitors in the presence of visceral crisis at diagnosis was linked with an improvement in overall survival.
Study results show that a caregiver’s involvement can significantly moderate patient activation and adherence to treatment.
Research shows that patients and healthcare providers differ in terms of their preference regarding release of radiology results.
Evaluation of real-world reports will help with the early clinical assessment of interstitial lung disease potentially associated with CDK4/6 inhibitors.
An electronic home-based multidimensional cancer survivorship program did not clearly affect outcomes in women with breast cancer, although a positive impact was revealed in interviews.
Pooled analyses of overall survival shows the addition of CDK inhibitors to fulvestrant confers a consistent survival benefit in patients with breast cancer.
As mutation-associated targeted therapies are identified, it is critical to address genetic testing disparities.
CDK4/6 inhibitors have similar efficacy; therefore, clinicians should consider toxicity when selecting an optimal therapeutic approach.
Page 1 of 21
Results 1 - 10 of 202